Acelyrin Inc (SLRN)

Nov 18, 2024

HC Wainwright Issues Positive Estimate for Acelyrin Earnings - MarketBeat

Nov 18, 2024

Nov 15, 2024

Acelyrin, Inc. (NASDAQ:SLRN) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024

Nov 15, 2024

TD Cowen maintains Buy rating on Acelyrin shares By Investing.com - Investing.com Canada

Nov 15, 2024

Nov 15, 2024

Acelyrin discloses ValenzaBio acquisition financials - Investing.com India

Nov 15, 2024

Nov 14, 2024

TD Cowen maintains Buy rating on Acelyrin shares - Investing.com

Nov 14, 2024

Nov 14, 2024

T. Rowe Price Investment Management, Inc. Reduces Stake in Acely - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Earnings call: Acelyrin focuses on TED treatment, eyes Phase 3 trials - Investing.com

Nov 14, 2024

Nov 14, 2024

Acelyrin Inc (SLRN) Q3 2024 Earnings Call Highlights: Strategic Pipeline Refocus and Financial ... By GuruFocus - Investing.com Canada

Nov 14, 2024

Nov 13, 2024

ACELYRIN, INC. Advances Key Drug Developments - TipRanks

Nov 13, 2024

Nov 13, 2024

ACELYRIN, INC. Reports Third Quarter 2024 Financial Results and Recent Highlights - The Manila Times

Nov 13, 2024

Nov 13, 2024

ACELYRIN Reports $562M Cash Position, Advances Key Clinical Trials Amid Pipeline Focus | SLRN Stock News - StockTitan

Nov 13, 2024

Nov 08, 2024

(SLRN) Investment Analysis and Advice - Stock Traders Daily

Nov 08, 2024

Nov 07, 2024

Acelyrin (SLRN) Set to Announce Earnings on Wednesday - MarketBeat

Nov 07, 2024

Nov 06, 2024

ACELYRIN, INC. to Report Third Quarter 2024 Financial Results and Corporate Update on November 13, 2024 - The Manila Times

Nov 06, 2024

Nov 06, 2024

ACELYRIN Sets Q3 2024 Earnings Call: Immunology Pipeline Updates Coming Nov 13 | SLRN Stock News - StockTitan

Nov 06, 2024

Nov 05, 2024

Vanguard Group Inc's Strategic Reduction in Acelyrin Inc Shares - GuruFocus.com

Nov 05, 2024

Oct 30, 2024

10 Best IPO Stocks To Buy Heading into 2025 - Insider Monkey

Oct 30, 2024

Oct 28, 2024

(SLRN) Proactive Strategies - Stock Traders Daily

Oct 28, 2024

Oct 28, 2024

Acelyrin, Inc. (NASDAQ:SLRN) Receives $11.17 Consensus PT from Analysts - MarketBeat

Oct 28, 2024

Oct 27, 2024

Acelyrin, Inc. (NASDAQ:SLRN) Short Interest Update - MarketBeat

Oct 27, 2024

Oct 20, 2024

The Manufacturers Life Insurance Company Acquires 4,163 Shares of Acelyrin, Inc. (NASDAQ:SLRN) - Defense World

Oct 20, 2024

Oct 18, 2024

Acelyrin (NASDAQ:SLRN) Trading Down 6.9%What's Next? - MarketBeat

Oct 18, 2024

Oct 18, 2024

(SLRN) Trading Advice - Stock Traders Daily

Oct 18, 2024

Oct 17, 2024

Acelyrin (NASDAQ:SLRN) Trading 4.8% Higher on Analyst Upgrade - MarketBeat

Oct 17, 2024

Oct 17, 2024

SLRNACELYRIN, INC. Latest Stock News & Market Updates - StockTitan

Oct 17, 2024

Oct 16, 2024

Wells Fargo & Company Boosts Acelyrin (NASDAQ:SLRN) Price Target to $15.00 - MarketBeat

Oct 16, 2024

Oct 16, 2024

ACELYRIN, INC. Forms Scientific and Patient Advisory Board Featuring Leading Voices in Thyroid Eye Disease - The Manila Times

Oct 16, 2024

Oct 14, 2024

Did Acelyrin Inc (SLRN) perform well in the last session? - US Post News

Oct 14, 2024

Oct 11, 2024

Acelyrin (NASDAQ:SLRN) Stock Price Down 2.4%Should You Sell? - MarketBeat

Oct 11, 2024

Oct 11, 2024

Acelyrin Inc (SLRN) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle

Oct 11, 2024

Oct 10, 2024

Acelyrin (NASDAQ:SLRN) Shares Up 5.9%Still a Buy? - MarketBeat

Oct 10, 2024

Oct 06, 2024

Acelyrin, Inc. (NASDAQ:SLRN) Shares Sold by Point72 Asset Management L.P. - MarketBeat

Oct 06, 2024

Oct 05, 2024

Millennium Management LLC Has $20.47 Million Stake in Acelyrin, Inc. (NASDAQ:SLRN) - MarketBeat

Oct 05, 2024

Oct 04, 2024

Renaissance Technologies LLC Has $1.75 Million Stake in Acelyrin, Inc. (NASDAQ:SLRN) - MarketBeat

Oct 04, 2024

Oct 03, 2024

160,167 Shares in Acelyrin, Inc. (NASDAQ:SLRN) Bought by Susquehanna Fundamental Investments LLC - Defense World

Oct 03, 2024

Oct 03, 2024

Susquehanna Fundamental Investments LLC Takes Position in Acelyrin, Inc. (NASDAQ:SLRN) - MarketBeat

Oct 03, 2024

Oct 03, 2024

Acelyrin, Inc. (NASDAQ:SLRN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Oct 03, 2024

Oct 02, 2024

Recent Insider Activity Suggests Potential Gains for Acelyrin Inc (SLRN) - Knox Daily

Oct 02, 2024

Sep 29, 2024

Almitas Capital LLC Buys New Position in Acelyrin, Inc. (NASDAQ:SLRN) - MarketBeat

Sep 29, 2024

Sep 25, 2024

Piper Sandler maintains Overweight rating on Acelyrin shares - Investing.com

Sep 25, 2024

Sep 25, 2024

Piper Sandler maintains Overweight rating on Acelyrin shares By Investing.com - Investing.com Australia

Sep 25, 2024

Sep 25, 2024

Acelyrin Inc [SLRN] Director makes an insider sale of 1 shares worth $7.0. - Knox Daily

Sep 25, 2024

Sep 25, 2024

Top investors say Acelyrin Inc (SLRN) ticks everything they need - SETE News

Sep 25, 2024

Sep 25, 2024

Acelyrin Insider Sellers Miss The Bus As Stock Jumps 12% - Simply Wall St

Sep 25, 2024

Sep 24, 2024

Can Acelyrin Inc Bounce Back? 52-Week Performance and Analyst Predictions - The InvestChronicle

Sep 24, 2024

Sep 23, 2024

Acelyrin (NASDAQ:SLRN) Shares Down 5.4% - MarketBeat

Sep 23, 2024

Sep 23, 2024

How did Acelyrin Inc (SLRN) fare last session? - US Post News

Sep 23, 2024

Sep 20, 2024

Acelyrin: Straight Move To Phase 3 TED Studies Makes It Must Watch (NASDAQ:SLRN) - Seeking Alpha

Sep 20, 2024

Sep 19, 2024

Acelyrin (NASDAQ:SLRN) Shares Gap Up to $4.60 - MarketBeat

Sep 19, 2024

Sep 19, 2024

Acelyrin stock spikes on upcoming presentation (NASDAQ:SLRN) - Seeking Alpha

Sep 19, 2024

Sep 19, 2024

Acelyrin announces positive results from Phase 3 trial of izokibep - TipRanks

Sep 19, 2024

Sep 19, 2024

ACELYRIN, INC. Announces Positive Results from Global Phase 3 Clinical Trial of Izokibep in Hidradenitis Suppurativa to be Highlighted in Late-Breaking Oral Presentation at EADV 2024 - StockTitan

Sep 19, 2024